Home
 /
Papers
 /
Molecular Biology
 /
Cryo-EM as latent structural landscape microscopy
Preprint
Open access
Top 1% · Validated by QED

Cryo-EM as latent structural landscape microscopy

Haizhao Dai, Qihe Chen, Lingqi Li +10 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.04.10.717737
99
%
QED Score
QED Impressions

By grounding cryo-EM latent spaces in physical probability distributions and validating them against molecular dynamics, this work overturns the discrete-class paradigm and makes rare conformational intermediates and continuous transition pathways directly accessible from experimental data.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

Cryo-EM particle images encode a physically grounded conformational landscape where latent density quantitatively reflects the probabilistic distribution of molecular states according to Boltzmann statistics, enabling automated discovery of low-population intermediate states invisible to conventional methods, direct experimental resolution of continuous conformational pathways, and energy-guided particle selection that improves reconstruction quality.

See full analysis
Main Claim 1 –

CryoUNI Latent Density Encodes Boltzmann Conformational Energy Landscapes

Supporting evidence

  • CryoUNI Latent PCs Match Integrin Leg Angles from MD
  • WAVE Detects Density-Peak States Without Predefined State Number
Main Claim 2 –

Latent Landscape Reveals Low-Population Binding-Mode Intermediates

Main Claim 3 –

Energy-Guided Particle Selection Improves Resolution and Maps Pathways

Abstract

A protein populates a landscape of structural states, abundant snapshots of which are sampled in every cryo-EM experiment. Current analysis averages these snapshots into single density maps or partitions them into discrete classes, discarding the continuous dynamics encoded in the data. Continuous latent-space methods offer a promising alternative, yet whether their learned representations are physically grounded remains unresolved. Here, we realize cryo-EM as structural landscape microscopy, in which latent density directly reflects the probabilistic distribution of molecular states. A central question is whether such a landscape reflects physical reality. For integrin αvβ8, the learned landscape shows strong agreement with independently derived molecular dynamics simulations, supporting its physical plausibility. We then apply the landscape to structural states that conventional cryo-EM cannot resolve. For LIS1-mediated dynein activation, the landscape reveals a spectrum of states from dominant conformations to low-population intermediates defined by distinct binding modes, including a previously unresolved state. For the KCTD5/CUL3NTD/Gβγ complex, the landscape resolves continuous conformational pathways directly from experimental data. Probability-guided particle selection further improves reconstruction quality.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?